IRIS Accounts Production v24.1.0.578 02059202 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh020592022022-12-31020592022023-12-31020592022023-01-012023-12-31020592022021-12-31020592022022-01-012022-12-31020592022022-12-3102059202ns15:EnglandWales2023-01-012023-12-3102059202ns14:PoundSterling2023-01-012023-12-3102059202ns10:Director12023-01-012023-12-3102059202ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3102059202ns10:SmallEntities2023-01-012023-12-3102059202ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3102059202ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3102059202ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3102059202ns10:FullAccounts2023-01-012023-12-310205920212023-01-012023-12-3102059202ns10:OrdinaryShareClass12023-01-012023-12-3102059202ns10:Director22023-01-012023-12-3102059202ns10:RegisteredOffice2023-01-012023-12-3102059202ns5:CurrentFinancialInstruments2023-12-3102059202ns5:CurrentFinancialInstruments2022-12-3102059202ns5:Non-currentFinancialInstruments2023-12-3102059202ns5:Non-currentFinancialInstruments2022-12-3102059202ns5:ShareCapital2023-12-3102059202ns5:ShareCapital2022-12-3102059202ns5:RetainedEarningsAccumulatedLosses2023-12-3102059202ns5:RetainedEarningsAccumulatedLosses2022-12-3102059202ns5:NetGoodwill2023-01-012023-12-3102059202ns5:FurnitureFittings2023-01-012023-12-3102059202ns5:MotorVehicles2023-01-012023-12-3102059202ns5:ComputerEquipment2023-01-012023-12-3102059202ns5:NetGoodwill2022-12-3102059202ns5:NetGoodwill2023-12-3102059202ns5:NetGoodwill2022-12-3102059202ns5:ShortLeaseholdAssetsns5:LandBuildings2022-12-3102059202ns5:FurnitureFittings2022-12-3102059202ns5:MotorVehicles2022-12-3102059202ns5:ComputerEquipment2022-12-3102059202ns5:ShortLeaseholdAssetsns5:LandBuildings2023-01-012023-12-3102059202ns5:ShortLeaseholdAssetsns5:LandBuildings2023-12-3102059202ns5:FurnitureFittings2023-12-3102059202ns5:MotorVehicles2023-12-3102059202ns5:ComputerEquipment2023-12-3102059202ns5:ShortLeaseholdAssetsns5:LandBuildings2022-12-3102059202ns5:FurnitureFittings2022-12-3102059202ns5:MotorVehicles2022-12-3102059202ns5:ComputerEquipment2022-12-3102059202ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3102059202ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3102059202ns5:DeferredTaxation2022-12-3102059202ns5:DeferredTaxation2023-01-012023-12-3102059202ns5:DeferredTaxation2023-12-3102059202ns10:OrdinaryShareClass12023-12-31
REGISTERED NUMBER: 02059202 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

RADPHARM LIMITED

RADPHARM LIMITED (REGISTERED NUMBER: 02059202)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


RADPHARM LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTORS: Mrs S Radia
Mr S C Radia





REGISTERED OFFICE: Unit 2.02
High Weald House
Glovers End
Bexhill
East Sussex
TN39 5ES





REGISTERED NUMBER: 02059202 (England and Wales)





ACCOUNTANTS: Acuity Professional Partnership LLP
Unit 2.02
High Weald House
Glovers End
Bexhill
East Sussex
TN39 5ES

RADPHARM LIMITED (REGISTERED NUMBER: 02059202)

STATEMENT OF FINANCIAL POSITION
31 DECEMBER 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Property, plant and equipment 5 9,970 10,825
9,970 10,825

CURRENT ASSETS
Inventories 6 85,307 76,869
Debtors 7 3,859,129 3,748,648
Cash at bank and in hand 62,307 43,228
4,006,743 3,868,745
CREDITORS
Amounts falling due within one year 8 674,472 685,862
NET CURRENT ASSETS 3,332,271 3,182,883
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,342,241

3,193,708

CREDITORS
Amounts falling due after more than one
year

9

(32,314

)

(37,647

)

PROVISIONS FOR LIABILITIES 10 (1,848 ) (1,460 )
NET ASSETS 3,308,079 3,154,601

CAPITAL AND RESERVES
Called up share capital 11 100 100
Retained earnings 3,307,979 3,154,501
SHAREHOLDERS' FUNDS 3,308,079 3,154,601

RADPHARM LIMITED (REGISTERED NUMBER: 02059202)

STATEMENT OF FINANCIAL POSITION - continued
31 DECEMBER 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 September 2024 and were signed on its behalf by:





Mr S C Radia - Director


RADPHARM LIMITED (REGISTERED NUMBER: 02059202)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023


1. STATUTORY INFORMATION

Radpharm Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

GOODWILL
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of twenty years.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 10% on cost
Motor vehicles - 25% on cost
Computer equipment - 33% on cost

STOCKS
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 23 (2022 - 22 ) .

RADPHARM LIMITED (REGISTERED NUMBER: 02059202)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


4. INTANGIBLE FIXED ASSETS
Goodwill
£   
Cost
At 1 January 2023
and 31 December 2023 89,825
Amortisation
At 1 January 2023
and 31 December 2023 89,825
Net book value
At 31 December 2023 -
At 31 December 2022 -

5. PROPERTY, PLANT AND EQUIPMENT
Fixtures
Short and Motor Computer
leasehold fittings vehicles equipment Totals
£    £    £    £    £   
Cost
At 1 January 2023 1,952 235,512 20,617 42,935 301,016
Additions - 184 - 2,848 3,032
At 31 December 2023 1,952 235,696 20,617 45,783 304,048
Depreciation
At 1 January 2023 1,952 230,412 20,617 37,210 290,191
Charge for year - 1,322 - 2,565 3,887
At 31 December 2023 1,952 231,734 20,617 39,775 294,078
Net book value
At 31 December 2023 - 3,962 - 6,008 9,970
At 31 December 2022 - 5,100 - 5,725 10,825

6. INVENTORIES
31.12.23 31.12.22
£    £   
Finished goods 85,307 76,869

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade debtors 281,725 280,813
Amounts owed by group undertakings 3,575,519 3,466,018
Other debtors 1,885 1,817
3,859,129 3,748,648

RADPHARM LIMITED (REGISTERED NUMBER: 02059202)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Bank loans and overdrafts 5,334 5,202
Trade creditors 468,967 448,125
Taxation and social security 49,641 89,986
Other creditors 150,530 142,549
674,472 685,862

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.23 31.12.22
£    £   
Bank loans 32,314 37,647

10. PROVISIONS FOR LIABILITIES
31.12.23 31.12.22
£    £   
Deferred tax 1,848 1,460

Deferred
tax
£   
Balance at 1 January 2023 1,460
Provided during year 388
Accelerated capital allowances
Balance at 31 December 2023 1,848

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.23 31.12.22
value: £    £   
100 Ordinary £1 100 100